58 reports

Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. The global injectable drug delivery devices market is expected to grow from $34.49...

  • Drug Delivery
  • Injectable Delivery
  • World
  • Western Europe
  • United States
  • APAC

Injectable Drug Delivery market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Injectable Drug Delivery Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Injectable Drug Delivery types, applications. Further,...

  • Injectable Delivery
  • World

Injectable Drug Delivery Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Injectable Drug Delivery Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Injectable Drug Delivery Devices types,...

  • Injectable Delivery
  • World

Injectable Drug Delivery Technology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Injectable Drug Delivery Technology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Injectable Drug Delivery Technology...

  • Injectable Delivery
  • Drug Delivery
  • World

Major players in the injectable drug market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. The global injectable drug delivery devices market is expected to grow from $15.38 billion in 2020...

  • Injectable Delivery
  • Drug Delivery
  • World

Injectable Drug Delivery Market Report Overview Injectable Drug Delivery market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Injectable Drug Delivery market types and applications. It is a focused study on Injectable Drug Delivery market...

  • Injectable Delivery
  • World
  • Health Provider Density

Injectable Drug Delivery Devices Market Report Overview Injectable Drug Delivery Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Injectable Drug Delivery Devices market types and applications. It is a focused study on Injectable...

  • Injectable Delivery
  • World
  • Health Provider Density

Injectable Drug Delivery Technology Market Report Overview Injectable Drug Delivery Technology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Injectable Drug Delivery Technology market types and applications. It is a focused study...

  • Injectable Delivery
  • World
  • Health Provider Density

Global Injectable Drug Delivery Devices Market 2022-2026 The analyst has been monitoring the injectable drug delivery devices market and it is poised to grow by $ 22.29 bn during 2022-2026, decelerating at a CAGR of 8.48% during the forecast period. Our report on the injectable drug delivery devices market provides a holistic...

  • Injectable Delivery
  • World
  • Chronic Disease Prevalence

Injectable Drug Delivery Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Injectable Drug Delivery market including the COVID-19 pandemic implications...

  • Injectable Delivery
  • APAC
  • Central America

Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Injectable Drug Delivery Devicess pipeline products with...

  • Injectable Delivery
  • Drug Development
  • Clinical Trial

Abstract: - Global Injectable Drugs Delivery Market to Reach $852.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Injectable Drugs Delivery estimated at US$437.9 Billion in the year 2020, is projected to reach a revised size of US$852.2 Billion by 2027, growing at aCAGR of 10% over the period 2020-2027....

  • Injectable Delivery
  • World
  • China
  • United States

Injectable Drug Delivery Market: Scope of the Report The analyst recently published a market study on the global injectable drug delivery market.The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the injectable drug...

  • Injectable Delivery
  • World

Market Overview The injectable drug delivery devices market will show rapid growth due to the increasing prevalence of chronic diseases, benefits and convenience leading to increased demand of self injectors and growth of biologics market leading to increased demand for injectors. The increasing prevalence of...

  • Injectable Delivery
  • Pharmaceutical
  • APAC
  • Diabetes Prevalence
  • Cancer Incidence

Injectable Drug Delivery Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Injectable Drug Delivery Market Size, Outlook and Growth Opportunities to 2025: By Type (Formulation, Devices), By Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), By End User...

  • Injectable Delivery
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

INTRODUCTION Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....

  • Drug Delivery
  • Injectable Delivery
  • Insulin
  • World
  • Europe
  • APAC
  • North America
  • Number Of Enterprises
  • Chronic Disease Prevalence

The North America syringe market is projected to reach US$ 9,612.96 million by 2027 from US$ 4,427.49 million in 2019; it is estimated to grow at a CAGR of 10.1% from 2020 to 2027. The growth of the North America syringe market is driven by factors such as growing number of chronic and infectious diseases and increasing adoption of...

  • Injectable Delivery
  • North America
  • United States
  • Chronic Disease Prevalence
  • Cosmetic Procedures Performed

The Europe syringe market is projected to reach US$ 8,707.80 million by 2027 from US$ 4,238.29 million in 2019; the market is estimated to grow at CAGR of 9.3% from 2020 to 2027. The growth of the Europe syringe market is driven by factors such as growing number of chronic and infectious diseases, and increasing use of injectable drugs....

  • Injectable Delivery
  • Europe
  • Health Expenditure
  • Cause-Specific Mortality Rate

Major players in the prefilled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc, Baxter International Inc, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, and Weigao Group. The global pre filled syringes market is expected to grow...

  • Injectable Delivery
  • World
  • United States
  • APAC
  • United Kingdom

Major players in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott Group, West Pharmaceutical Services Inc., Baxter International Inc., Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group, Weigao Group, Novartis, Catalent Inc., Unilife Corporation, Eli Lilly and Company,...

  • Injectable Delivery
  • Pharmaceutical Packaging
  • World
  • United States
  • APAC
  • United Kingdom

INTRODUCTION According to the National Health Interview Survey (NHIS), nearly 52% of the adult population in the US is diagnosed with at least one chronic condition, such as asthma, diabetes, and hypertension. The annual cost burden associated with chronic disorders in the US is around USD 3.7 trillion; this accounts for...

  • Injectable Delivery
  • World
  • APAC
  • Drug Approval
  • Lead Price

INTRODUCTION Chronic diseases are considered to be the leading causes of deaths and disability. In fact, globally, such diseases are known to be responsible for two third of the overall deaths. Within the US, nearly 52% of the adult population is presently living with at least one chronic condition, while 27% of the US...

  • Injectable Delivery
  • World
  • APAC
  • Europe
  • North America
  • United States
  • Chronic Disease Prevalence

Summary Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions.Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular...

  • Injectable Delivery
  • United States
  • World
  • North America
  • Drug Approval
  • Medical Devices Sales

A recent market study published on the Needle-Free Injectors market offers a global industry analysis for 2016-2020 and an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the...

  • Injectable Delivery
  • World

INTRODUCTION More than 40% of the US population is estimated to be suffering from some form of a chronic health condition. According to the US National Health Council, over 75% of the nation’s healthcare expenditure is on the treatment of chronic diseases, such as diabetes. The major share of expenses incurred by patients...

  • Injectable Delivery
  • World
  • United States
  • APAC
  • Drug Approval
  • Health Expenditure

Abstract: - Global Needles Market to Reach $10.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Needles estimated at US$6.5 Billion in the year 2020, is projected to reach a revised size of US$10.2 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Conventional Needles, one of the...

  • Injectable Delivery
  • World
  • United States
  • China

This study covers the world outlook for injectable drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Injectable Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for injectable drug delivery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Injectable Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for injectable drug delivery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Injectable Delivery
  • World
  • Gross Domestic Product
  • Disposable Income

KEY FINDINGS The global injectable drugs delivery market is expected to grow at a CAGR of 8.73% between 2019 and 2027. The market is mostly dominated by the home based end-user because these devices are made in a way that they are intended for self-administration by patients, or administration by untrained personnel. MARKET...

  • Injectable Delivery
  • World
  • Elderly Population
  • Health Expenditure